Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 347

1.

Malignant tumors in autoimmune encephalitis with anti-NMDA receptor antibodies.

Bost C, Chanson E, Picard G, Meyronet D, Mayeur ME, Ducray F, Rogemond V, Psimaras D, Antoine JC, Delattre JY, Desestret V, Honnorat J.

J Neurol. 2018 Jul 12. doi: 10.1007/s00415-018-8970-0. [Epub ahead of print]

PMID:
30003358
2.

Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodies.

Vialatte de Pémille C, Berzero G, Small M, Psimaras D, Giry M, Daniau M, Sanson M, Delattre JY, Honnorat J, Desestret V, Alentorn A.

Br J Cancer. 2018 Jun 14. doi: 10.1038/s41416-018-0125-7. [Epub ahead of print]

PMID:
29899393
3.

Immune-mediated ataxias.

Joubert B, Rostásy K, Honnorat J.

Handb Clin Neurol. 2018;155:313-332. doi: 10.1016/B978-0-444-64189-2.00021-4.

PMID:
29891069
4.

GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies.

Liimatainen S, Honnorat J, Pittock SJ, McKeon A, Manto M, Radtke JR; T1D Exchange Biobank, Hampe CS.

Orphanet J Rare Dis. 2018 Apr 10;13(1):55. doi: 10.1186/s13023-018-0787-5.

5.

Autoimmune encephalitis and psychiatric disorders.

Honnorat J, Plazat LO.

Rev Neurol (Paris). 2018 Apr;174(4):228-236. doi: 10.1016/j.neurol.2017.11.004. Epub 2018 Mar 31. Review.

PMID:
29609960
6.

Molecular Pathogenicity of Anti-NMDA Receptor Autoantibody From Patients With First-Episode Psychosis.

Jézéquel J, Lepleux M, Kahn RS, Honnorat J, Leboyer M, Groc L.

Am J Psychiatry. 2018 Apr 1;175(4):382-383. doi: 10.1176/appi.ajp.2017.17091053. No abstract available.

PMID:
29606071
7.

Nivolumab-induced myositis: A case report and a literature review.

Bourgeois-Vionnet J, Joubert B, Bernard E, Sia MA, Pante V, Fabien N, Honnorat J, Streichenberger N.

J Neurol Sci. 2018 Apr 15;387:51-53. doi: 10.1016/j.jns.2018.01.030. Epub 2018 Feb 3. No abstract available.

PMID:
29571871
8.

Temozolomide Plus Bevacizumab in Elderly Patients with Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial (ATAG).

Reyes-Botero G, Cartalat-Carel S, Chinot OL, Barrie M, Taillandier L, Beauchesne P, Catry-Thomas I, Barrière J, Guillamo JS, Fabbro M, Frappaz D, Benouaich-Amiel A, Le Rhun E, Campello C, Tennevet I, Ghiringhelli F, Tanguy ML, Mokhtari K, Honnorat J, Delattre JY.

Oncologist. 2018 May;23(5):524-e44. doi: 10.1634/theoncologist.2017-0689. Epub 2018 Feb 22.

9.

Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical Trial.

Taphoorn MJB, Dirven L, Kanner AA, Lavy-Shahaf G, Weinberg U, Taillibert S, Toms SA, Honnorat J, Chen TC, Sroubek J, David C, Idbaih A, Easaw JC, Kim CY, Bruna J, Hottinger AF, Kew Y, Roth P, Desai R, Villano JL, Kirson ED, Ram Z, Stupp R.

JAMA Oncol. 2018 Apr 1;4(4):495-504. doi: 10.1001/jamaoncol.2017.5082.

10.

Rechallenge with bevacizumab in patients with glioblastoma progressing off therapy.

Bronnimann C, Izquierdo C, Cartalat S, Thomas L, Joubert B, Delpech L, Barritault M, Meyronet D, Honnorat J, Ducray F.

J Neurooncol. 2018 May;138(1):141-145. doi: 10.1007/s11060-018-2780-1. Epub 2018 Jan 31.

PMID:
29388033
11.

Glioblastoma as differential diagnosis of autoimmune encephalitis.

Vogrig A, Joubert B, Ducray F, Thomas L, Izquierdo C, Decaestecker K, Martinaud O, Gerardin E, Grand S, Honnorat J.

J Neurol. 2018 Mar;265(3):669-677. doi: 10.1007/s00415-018-8767-1. Epub 2018 Jan 30.

PMID:
29383516
12.

Multiplex family with GAD65-Abs neurologic syndromes.

Belbezier A, Joubert B, Montero-Martin G, Fernandez-Vina M, Fabien N, Rogemond V, Mignot E, Honnorat J.

Neurol Neuroimmunol Neuroinflamm. 2017 Dec 5;5(1):e416. doi: 10.1212/NXI.0000000000000416. eCollection 2018 Jan.

13.

Effect of thymectomy on refractory autoimmune status epilepticus.

Vogrig A, Pauletto G, Belgrado E, Pegolo E, Di Loreto C, Rogemond V, Honnorat J, Eleopra R.

J Neuroimmunol. 2018 Apr 15;317:90-94. doi: 10.1016/j.jneuroim.2018.01.009. Epub 2018 Jan 9.

PMID:
29336839
14.

Initial clinical presentation of young children with N-methyl-d-aspartate receptor encephalitis.

Favier M, Joubert B, Picard G, Rogemond V, Thomas L, Rheims S, Bailhache M, Villega F, Pédespan JM, Berzero G, Psimaras D, Antoine JC, Desestret V, Honnorat J.

Eur J Paediatr Neurol. 2018 May;22(3):404-411. doi: 10.1016/j.ejpn.2017.12.014. Epub 2017 Dec 28.

PMID:
29310866
15.

Complex HLA association in paraneoplastic cerebellar ataxia with anti-Yo antibodies.

Hillary RP, Ollila HM, Lin L, Desestret V, Rogemond V, Picard G, Small M, Arnulf I, Dauvilliers Y, Honnorat J, Mignot E.

J Neuroimmunol. 2018 Feb 15;315:28-32. doi: 10.1016/j.jneuroim.2017.12.012. Epub 2017 Dec 18.

PMID:
29306402
16.

Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration.

Small M, Treilleux I, Couillault C, Pissaloux D, Picard G, Paindavoine S, Attignon V, Wang Q, Rogemond V, Lay S, Ray-Coquard I, Pfisterer J, Joly F, Du Bois A, Psimaras D, Bendriss-Vermare N, Caux C, Dubois B, Honnorat J, Desestret V.

Acta Neuropathol. 2018 Apr;135(4):569-579. doi: 10.1007/s00401-017-1802-y. Epub 2018 Jan 3.

PMID:
29299667
17.

Characteristics of cerebellar glioblastomas in adults.

Picart T, Barritault M, Berthillier J, Meyronet D, Vasiljevic A, Frappaz D, Honnorat J, Jouanneau E, Poncet D, Ducray F, Guyotat J.

J Neurooncol. 2018 Feb;136(3):555-563. doi: 10.1007/s11060-017-2682-7. Epub 2017 Dec 1.

PMID:
29196927
18.

Dynamic disorganization of synaptic NMDA receptors triggered by autoantibodies from psychotic patients.

Jézéquel J, Johansson EM, Dupuis JP, Rogemond V, Gréa H, Kellermayer B, Hamdani N, Le Guen E, Rabu C, Lepleux M, Spatola M, Mathias E, Bouchet D, Ramsey AJ, Yolken RH, Tamouza R, Dalmau J, Honnorat J, Leboyer M, Groc L.

Nat Commun. 2017 Nov 27;8(1):1791. doi: 10.1038/s41467-017-01700-3.

19.

Long-term impact of temozolomide on 1p/19q-codeleted low-grade glioma growth kinetics.

Izquierdo C, Alentorn A, Idbaih A, Simó M, Kaloshi G, Ricard D, Barritault M, Meyronet D, Bruna J, Honnorat J, Delattre JY, Ducray F.

J Neurooncol. 2018 Feb;136(3):533-539. doi: 10.1007/s11060-017-2677-4. Epub 2017 Nov 15.

PMID:
29143276
20.

Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies.

Berzero G, Karantoni E, Dehais C, Ducray F, Thomas L, Picard G, Rogemond V, Candelier G, Camdessanché JP, Antoine JC, De Seze J, Liou-Schischmanoff A, Honnorat J, Delattre JY, Psimaras D.

J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):789-792. doi: 10.1136/jnnp-2017-316904. Epub 2017 Oct 30. No abstract available.

21.

Transcriptional regulation of CRMP5 controls neurite outgrowth through Sox5.

Naudet N, Moutal A, Vu HN, Chounlamountri N, Watrin C, Cavagna S, Malleval C, Benetollo C, Bardel C, Dronne MA, Honnorat J, Meissirel C, Besançon R.

Cell Mol Life Sci. 2018 Jan;75(1):67-79. doi: 10.1007/s00018-017-2634-6. Epub 2017 Sep 1.

PMID:
28864883
22.

Cell- and Single Molecule-Based Methods to Detect Anti-N-Methyl-D-Aspartate Receptor Autoantibodies in Patients With First-Episode Psychosis From the OPTiMiSE Project.

Jézéquel J, Rogemond V, Pollak T, Lepleux M, Jacobson L, Gréa H, Iyegbe C, Kahn R, McGuire P, Vincent A, Honnorat J, Leboyer M, Groc L.

Biol Psychiatry. 2017 Nov 15;82(10):766-772. doi: 10.1016/j.biopsych.2017.06.015. Epub 2017 Jul 6.

PMID:
28780967
23.

The Syk kinases orchestrate cerebellar granule cell tangential migration.

Benon A, Ya C, Martin L, Watrin C, Chounlamountri N, Jaaoini I, Honnorat J, Pellier-Monnin V, Noraz N.

Neuroscience. 2017 Sep 30;360:230-239. doi: 10.1016/j.neuroscience.2017.07.057. Epub 2017 Jul 30.

PMID:
28768156
24.

Autoimmune episodic ataxia in patients with anti-CASPR2 antibody-associated encephalitis.

Joubert B, Gobert F, Thomas L, Saint-Martin M, Desestret V, Convers P, Rogemond V, Picard G, Ducray F, Psimaras D, Antoine JC, Delattre JY, Honnorat J.

Neurol Neuroimmunol Neuroinflamm. 2017 Jun 14;4(4):e371. doi: 10.1212/NXI.0000000000000371. eCollection 2017 Jul.

25.

Clinical and autoimmune features of a patient with autism spectrum disorder seropositive for anti-NMDA-receptor autoantibody.

Gréa H, Scheid I, Gaman A, Rogemond V, Gillet S, Honnorat J, Bolognani F, Czech C, Bouquet C, Toledano E, Bouvard M, Delorme R, Groc L, Leboyer M.

Dialogues Clin Neurosci. 2017 Mar;19(1):65-70.

26.

Methionine tumor starvation by erythrocyte-encapsulated methionine gamma-lyase activity controlled with per os vitamin B6.

Gay F, Aguera K, Sénéchal K, Tainturier A, Berlier W, Maucort-Boulch D, Honnorat J, Horand F, Godfrin Y, Bourgeaux V.

Cancer Med. 2017 Jun;6(6):1437-1452. doi: 10.1002/cam4.1086. Epub 2017 May 23.

27.

[Adult intramedullary gliomas].

Campello C, Parker F, Slimani S, Le Floch A, Herbrecht A, Aghakhani N, Lacroix C, Loiseau H, Lejeune JP, Perrin G, Honnorat J, Dufour H, Chinot O, Figarella D, Bauchet L, Duffau H, Lonjon M, Labauge P, Messerer M, Daures JP, Fabbro P, Ducot B.

Neurochirurgie. 2017 Nov;63(5):381-390. doi: 10.1016/j.neuchi.2016.10.003. Epub 2017 May 18. French.

PMID:
28527519
28.

Ephrin-B3 supports glioblastoma growth by inhibiting apoptosis induced by the dependence receptor EphA4.

Royet A, Broutier L, Coissieux MM, Malleval C, Gadot N, Maillet D, Gratadou-Hupon L, Bernet A, Nony P, Treilleux I, Honnorat J, Liebl D, Pelletier L, Berger F, Meyronet D, Castets M, Mehlen P.

Oncotarget. 2017 Apr 4;8(14):23750-23759. doi: 10.18632/oncotarget.16077.

29.

Guidelines on the management of infectious encephalitis in adults.

Stahl JP, Azouvi P, Bruneel F, De Broucker T, Duval X, Fantin B, Girard N, Herrmann JL, Honnorat J, Lecuit M, Mailles A, Martinez-Almoyna L, Morand P, Piroth L, Tattevin P; reviewing group.

Med Mal Infect. 2017 May;47(3):179-194. doi: 10.1016/j.medmal.2017.01.005. Epub 2017 Apr 12. No abstract available.

PMID:
28412044
30.

Infectious encephalitis: Management without etiological diagnosis 48hours after onset.

Fillatre P, Crabol Y, Morand P, Piroth L, Honnorat J, Stahl JP, Lecuit M.

Med Mal Infect. 2017 May;47(3):236-251. doi: 10.1016/j.medmal.2017.02.004. Epub 2017 Mar 15. Review.

PMID:
28314470
31.

Netrin-1 receptor antibodies in thymoma-associated neuromyotonia with myasthenia gravis.

Torres-Vega E, Mancheño N, Cebrián-Silla A, Herranz-Pérez V, Chumillas MJ, Moris G, Joubert B, Honnorat J, Sevilla T, Vílchez JJ, Dalmau J, Graus F, García-Verdugo JM, Bataller L.

Neurology. 2017 Mar 28;88(13):1235-1242. doi: 10.1212/WNL.0000000000003778. Epub 2017 Mar 1.

32.

Paraneoplastic cerebellar degeneration associated with anti-ITPR1 antibodies.

Berzero G, Hacohen Y, Komorowski L, Scharf M, Dehais C, Leclercq D, Fourchotte V, Buecher B, Honnorat J, Graus F, Delattre JY, Psimaras D.

Neurol Neuroimmunol Neuroinflamm. 2017 Feb 3;4(2):e326. doi: 10.1212/NXI.0000000000000326. eCollection 2017 Mar. No abstract available.

33.

Characteristics of H3 K27M-mutant gliomas in adults.

Meyronet D, Esteban-Mader M, Bonnet C, Joly MO, Uro-Coste E, Amiel-Benouaich A, Forest F, Rousselot-Denis C, Burel-Vandenbos F, Bourg V, Guyotat J, Fenouil T, Jouvet A, Honnorat J, Ducray F.

Neuro Oncol. 2017 Aug 1;19(8):1127-1134. doi: 10.1093/neuonc/now274.

PMID:
28201752
34.

Characteristics in limbic encephalitis with anti-adenylate kinase 5 autoantibodies.

Do LD, Chanson E, Desestret V, Joubert B, Ducray F, Brugière S, Couté Y, Formaglio M, Rogemond V, Thomas-Antérion C, Borrega L, Laurens B, Tison F, Curot J, De Brouker T, Lebrun-Frenay C, Delattre JY, Antoine JC, Honnorat J.

Neurology. 2017 Feb 7;88(6):514-524. doi: 10.1212/WNL.0000000000003586. Epub 2017 Jan 6.

PMID:
28062719
35.

Analysis of temozolomide resistance in low-grade gliomas using a mechanistic mathematical model.

Ollier E, Mazzocco P, Ricard D, Kaloshi G, Idbaih A, Alentorn A, Psimaras D, Honnorat J, Delattre JY, Grenier E, Ducray F, Samson A.

Fundam Clin Pharmacol. 2017 Jun;31(3):347-358. doi: 10.1111/fcp.12259. Epub 2017 Jan 24.

PMID:
27933657
36.

Co-activation of VEGF and NMDA receptors promotes synaptic targeting of AMPA receptors.

De Rossi P, Harde E, Dupuis JP, Martin L, Chounlamountri N, Bardin M, Watrin C, Benetollo C, Pernet-Gallay K, Luhmann HJ, Honnorat J, Malleret G, Groc L, Acker-Palmer A, Salin PA, Meissirel C.

Mol Psychiatry. 2016 Dec;21(12):1647. doi: 10.1038/mp.2016.215. No abstract available.

PMID:
27847390
37.

Autoimmune encephalitis in psychiatric institutions: current perspectives.

Bost C, Pascual O, Honnorat J.

Neuropsychiatr Dis Treat. 2016 Oct 27;12:2775-2787. eCollection 2016. Review.

38.

Neuroleptic intolerance in patients with anti-NMDAR encephalitis.

Lejuste F, Thomas L, Picard G, Desestret V, Ducray F, Rogemond V, Psimaras D, Antoine JC, Delattre JY, Groc L, Leboyer M, Honnorat J.

Neurol Neuroimmunol Neuroinflamm. 2016 Aug 29;3(5):e280. doi: 10.1212/NXI.0000000000000280. eCollection 2016 Oct.

39.

Anti-N-Methyl-d-Aspartate Receptor Encephalitis in Adult Patients Requiring Intensive Care.

de Montmollin E, Demeret S, Brulé N, Conrad M, Dailler F, Lerolle N, Navellou JC, Schwebel C, Alves M, Cour M, Engrand N, Tonnelier JM, Maury E, Ruckly S, Picard G, Rogemond V, Magalhaes É, Sharshar T, Timsit JF, Honnorat J, Sonneville R; ENCEPHALITICA Study Group ‡.

Am J Respir Crit Care Med. 2017 Feb 15;195(4):491-499. doi: 10.1164/rccm.201603-0507OC.

PMID:
27552490
40.

Characterization of a Subtype of Autoimmune Encephalitis With Anti-Contactin-Associated Protein-like 2 Antibodies in the Cerebrospinal Fluid, Prominent Limbic Symptoms, and Seizures.

Joubert B, Saint-Martin M, Noraz N, Picard G, Rogemond V, Ducray F, Desestret V, Psimaras D, Delattre JY, Antoine JC, Honnorat J.

JAMA Neurol. 2016 Sep 1;73(9):1115-24. doi: 10.1001/jamaneurol.2016.1585.

PMID:
27428927
41.

Treatment of Progressive Multifocal Leukoencephalopathy With Mirtazapine.

Jamilloux Y, Kerever S, Ferry T, Broussolle C, Honnorat J, Sève P.

Clin Drug Investig. 2016 Oct;36(10):783-9. doi: 10.1007/s40261-016-0433-8. Review.

PMID:
27401779
42.

The cost-effectiveness of tumor-treating fields therapy in patients with newly diagnosed glioblastoma.

Bernard-Arnoux F, Lamure M, Ducray F, Aulagner G, Honnorat J, Armoiry X.

Neuro Oncol. 2016 Aug;18(8):1129-36. doi: 10.1093/neuonc/now102. Epub 2016 May 13.

43.

Syk kinases are required for spinal commissural axon repulsion at the midline via the ephrin/Eph pathway.

Noraz N, Jaaoini I, Charoy C, Watrin C, Chounlamountri N, Benon A, Malleval C, Boudin H, Honnorat J, Castellani V, Pellier-Monnin V.

Development. 2016 Jun 15;143(12):2183-93. doi: 10.1242/dev.128629. Epub 2016 Apr 27.

44.

Characteristics of gliomas in patients with somatic IDH mosaicism.

Bonnet C, Thomas L, Psimaras D, Bielle F, Vauléon E, Loiseau H, Cartalat-Carel S, Meyronet D, Dehais C, Honnorat J, Sanson M, Ducray F.

Acta Neuropathol Commun. 2016 Mar 31;4:31. doi: 10.1186/s40478-016-0302-y.

45.

Neuronal networks in mental diseases and neuropathic pain: Beyond brain derived neurotrophic factor and collapsin response mediator proteins.

Quach TT, Lerch JK, Honnorat J, Khanna R, Duchemin AM.

World J Psychiatry. 2016 Mar 22;6(1):18-30. doi: 10.5498/wjp.v6.i1.18. eCollection 2016 Mar 22. Review.

46.

Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes.

Storstein A, Raspotnig M, Vitaliani R, Giometto B, Graus F, Grisold W, Honnorat J, Vedeler CA.

J Neurol. 2016 May;263(5):1001-1007. doi: 10.1007/s00415-016-8090-7. Epub 2016 Mar 23.

PMID:
27007485
47.

Differential Effects of PI3K and Dual PI3K/mTOR Inhibition in Rat Prolactin-Secreting Pituitary Tumors.

Chanal M, Chevallier P, Raverot V, Fonteneau G, Lucia K, Monteserin Garcia JL, Rachwan A, Jouanneau E, Trouillas J, Honnorat J, Auger C, Theodoropoulou M, Raverot G.

Mol Cancer Ther. 2016 Jun;15(6):1261-70. doi: 10.1158/1535-7163.MCT-15-0891. Epub 2016 Mar 16.

48.

Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis.

Navarro V, Kas A, Apartis E, Chami L, Rogemond V, Levy P, Psimaras D, Habert MO, Baulac M, Delattre JY, Honnorat J; collaborators.

Brain. 2016 Apr;139(Pt 4):1079-93. doi: 10.1093/brain/aww012. Epub 2016 Mar 5.

PMID:
26945884
49.

Anti-NMDA-R encephalitis: Should we consider extreme delta brush as electrical status epilepticus?

Chanson E, Bicilli É, Lauxerois M, Kauffmann S, Chabanne R, Ducray F, Honnorat J, Clavelou P, Rosenberg S.

Neurophysiol Clin. 2016 Feb;46(1):17-25. doi: 10.1016/j.neucli.2015.12.009. Epub 2016 Feb 26.

PMID:
26922283
50.

Neuronal central nervous system syndromes probably mediated by autoantibodies.

Chefdeville A, Honnorat J, Hampe CS, Desestret V.

Eur J Neurosci. 2016 Jun;43(12):1535-52. doi: 10.1111/ejn.13212. Epub 2016 Mar 28. Review.

Supplemental Content

Loading ...
Support Center